Centene Aktie 1313733 / US15135B1017
57.80
USD
-1.03
USD
-1.75%
19.11.2024
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Centene Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | Centene Corp. | 0.00 | 0.00 | USD |
| 2022 | Centene Corp. | 0.00 | 0.00 | USD |
| 2021 | Centene Corp. | 0.00 | 0.00 | USD |
| 2020 | Centene Corp. | 0.00 | 0.00 | USD |
| 2019 | Centene Corp. | 0.00 | 0.00 | USD |
| 2018 | Centene Corp. | 0.00 | 0.00 | USD |
| 2017 | Centene Corp. | 0.00 | 0.00 | USD |
| 2016 | Centene Corp. | 0.00 | 0.00 | USD |
| 2015 | Centene Corp. | 0.00 | 0.00 | USD |
| 2014 | Centene Corp. | 0.00 | 0.00 | USD |
Gewinn je Aktie- Centene
| 2.3 17 | 2.3 18 | 3.1 19 | 3.1 20 | 2.3 21 | 2.1 22 | 5.0 23 |
Umsatz je Aktie- Centene
| 137 17 | 151 18 | 178 19 | 192 20 | 213 21 | 248 22 | 282 23 |
KGV- Centene
| 21.5 17 | 25.5 18 | 20.0 19 | 19.2 20 | 36.1 21 | 39.7 22 | 15.0 23 |
Centene Corp.: Die Aktie (in USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | 2.35 | 2.26 | 3.14 | 3.12 | 2.28 | 2.07 | 4.95 |
| Gewinn je Aktie unverwässert | 2.40 | 2.31 | 3.19 | 3.17 | 2.31 | 2.09 | 4.97 |
| Gewinn je Aktie verwässert | 2.34 | 2.26 | 3.14 | 3.12 | 2.28 | 2.07 | 4.95 |
| Dividende pro Aktie | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gesamtdividendenausschüttung in Mio. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Centene Corp.: Unternehmenskennzahlen (in USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 136.90 | 150.85 | 177.54 | 191.86 | 213.34 | 248.35 | 282.20 |
| KGV (Jahresendkurs, EPS unverwässert) | 21.53 | 25.53 | 20.01 | 19.23 | 36.12 | 39.71 | 14.99 |
| KGV (Jahresendkurs, EPS verwässert) | 21.53 | 25.53 | 20.01 | 19.23 | 36.12 | 39.71 | 14.99 |
| KGV (Jahresendkurs) | 21.53 | 25.53 | 20.01 | 19.23 | 36.12 | 39.71 | 14.99 |
| Dividendenrendite Jahresende in % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Eigenkapitalquote in % | 31.46 | 35.67 | 30.96 | 37.17 | 33.88 | 30.86 | 30.22 |
| Fremdkapitalquote in % | 68.54 | 64.33 | 69.04 | 62.83 | 66.12 | 69.14 | 69.78 |
Centene Corp.: GuV (in Mio. USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 48’382.00 | 60’116.00 | 74’639.00 | 111’115.00 | 125’982.00 | 144’547.00 | 153’999.00 |
| Umsatzveränderung in % | 19.15 | 24.25 | 24.16 | 48.87 | 13.38 | 14.74 | 6.54 |
| Bruttoergebnis vom Umsatz | - | - | - | - | - | - | - |
| Bruttoergebnisveränderung in % | - | - | - | - | - | - | - |
| Operatives Ergebnis | 1’218.00 | 1’879.00 | 2’137.00 | 3’734.00 | 3’488.00 | 3’859.00 | 3’615.00 |
| Veränderung Operatives Ergebnis in % | -18.20 | 54.27 | 13.73 | 74.73 | -6.59 | 10.64 | -6.32 |
| Ergebnis vor Steuern | 1’134.00 | 1’368.00 | 1’782.00 | 2’773.00 | 1’813.00 | 1’962.00 | 3’598.00 |
| Veränderung Ergebnis vor Steuern in % | -1.99 | 20.63 | 30.26 | 55.61 | -34.62 | 8.22 | 83.38 |
| Ergebnis nach Steuer | 828.00 | 900.00 | 1’321.00 | 1’808.00 | 1’347.00 | 1’202.00 | 2’702.00 |
| Veränderung Ergebnis nach Steuer in % | 48.12 | 8.70 | 46.78 | 36.87 | -25.50 | -10.76 | 124.79 |
Centene Corp.: Bilanz (in Mio. USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | 14’979 | 19’878 | 28’302 | 43’881 | 52’738 | 54’301 | 59’942 |
| Langzeit Gesamtverbindlichk. pro Aktie | - | - | - | - | - | - | - |
| Eigenkapital | 6’876 | 11’023 | 12’692 | 25’962 | 27’022 | 24’237 | 25’956 |
| Veränderung Eigenkapital in % | 16.20 | 59.37 | 14.97 | 105.35 | 3.97 | -10.22 | 7.41 |
| Bilanzsumme | 21’855 | 30’901 | 40’994 | 69’843 | 79’760 | 78’538 | 85’898 |
| Veränderung Bilanzsumme in % | 8.21 | 41.39 | 32.66 | 70.37 | 14.20 | -1.53 | 9.37 |
Centene Corp.: Sonstige Angaben (in USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 2.40 | 2.31 | 3.19 | 3.17 | 2.31 | 2.09 | 4.97 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 36.34 | -3.95 | 38.53 | -0.84 | -27.05 | -9.58 | 137.98 |
| Gewinn je Aktie (verwässert) | 2.34 | 2.26 | 3.14 | 3.12 | 2.28 | 2.07 | 4.95 |
| Veränderung Gewinn je Aktie (verwässert) in % | 36.72 | -3.61 | 39.13 | -0.65 | -26.93 | -9.46 | 139.75 |
| Anzahl Mitarbeiter | 33’700 | 47’300 | 56’600 | 71’300 | 72’500 | 74’300 | 76’000 |
| Veränderung Anzahl Mitarbeiter in % | 10.49 | 40.36 | 19.66 | 25.97 | 1.68 | 2.48 | 2.29 |
Centene Corp. Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Centene Corp. | Quartalszahlen | 11.02.2025 |
| Centene Corp. | Quartalszahlen | 29.04.2025 |
| Centene Corp. | Quartalszahlen | 29.07.2025 |
| Centene Corp. | Quartalszahlen | 28.10.2025 |
Centene Corp. vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 25.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 26.07.2024 |
| Hauptversammlung | Annual General Meeting | 14.05.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 26.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 06.02.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 24.10.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 28.07.2023 |
| Hauptversammlung | Annual General Meeting | 10.05.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 25.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 07.02.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 25.10.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 26.07.2022 |
| Hauptversammlung | Annual General Meeting | 26.04.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 26.04.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 08.02.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 98.91 |
| The Vanguard Group, Inc. | 12.12 |
| Vanguard Group, Inc. (Subfiler) | 11.43 |
| Harris Associates LP | 5.21 |
| Harris Associates LP | 5.21 |
| State Street Corp. | 4.65 |
| Capital Research & Management Co. (World Investors) | 4.47 |
| Capital Research & Management Co. (World Investors) | 4.47 |
| Norges Bank (13F) | 4.20 |
| Vanguard Total Stock Market ETF | 3.30 |
| Wellington Management Co. LLP (Wellington Breakout) | 3.17 |
| BlackRock Fund Advisors | 3.06 |
| Vanguard 500 Index Fund | 2.73 |
| Geode Capital Management LLC | 2.51 |
| Politan Capital Management LP | 2.40 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 56’600 | 71’300 | 72’500 | 74’300 | 76’000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1.32 | 1.56 | 1.74 | 1.95 | 2.03 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 20’323 | 23’393 | 28’497 | 30’128 | 40’756 |
| Summe Anlagevermögen | 20’671 | 46’450 | 51’263 | 48’410 | 45’142 |
| Summe Aktiva | 40’994 | 69’843 | 79’760 | 78’538 | 85’898 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 14’509 | 18’317 | 22’661 | 21’333 | 18’877 |
| Summe Fremdkapital | 28’302 | 43’881 | 52’738 | 54’301 | 59’942 |
| Summe Eigenkapital | 12’692 | 25’962 | 27’022 | 24’237 | 25’956 |
| Summe Passiva | 40’994 | 69’843 | 79’760 | 78’538 | 85’898 |
Adresse
| 7700 Forsyth Boulevard, 63105 St. Louis | |
| Telefon | +1 (314) 725-4477 |
| URL | http://www.centene.com |
Management
|
Alice Hm Chen
Chief Health Officer |
|
Andrew Lynn Asher
Chief Financial Officer & Executive Vice President |
|
Anika Gardenhire
Chief Customer Experience Officer |
|
Ashlee Knuckey
Chief Risk, Ethics & Compliance Officer |
|
Beau Garverick
Senior Vice President |
|
Brian P. LeClaire
Chief Information Officer |
|
Chan See Wing Arvan
Chief Operating Officer-International & Senior VP |
|
Christopher A. Koster
Secretary, Executive VP & General Counsel |
|
Christopher J. Coughlin
Independent Director |
|
Colin Toney
Executive Vice President-Mergers & Acquisitions |
|
David P. Thomas
Executive Vice President-Markets |
|
Frederick H. Eppinger
Chairman |
|
Gerald Roberts
Vice President-Strategy & Business Development |
|
H. James Dallas
Independent Director |
|
Jennifer Gilligan
Senior VP-Finance & Investor Relations |
|
Jessica L. Blume
Independent Director |
|
Jonathan L. Dinesman
Executive Vice President-External Affairs |
|
Katie N. Casso
Chief Accounting Officer, Senior VP & Controller |
|
Kenneth A. Burdick
Director |
|
Kenneth J. Fasola
President |
|
Kevin J. Counihan
Senior Vice President-Products |
|
Lori J. Robinson
Independent Director |
|
Michael A. Carson
President-Medicare & CEO-Medicare |
|
Monte E. Ford
Independent Director |
|
Nathan Landsbaum
CEO-Markets & Medicaid |
|
Richard Fisher
Senior Vice President |
|
Sarah McGinty London
Chief Executive Officer & Director |
|
Susan Smith
Chief Operating Officer |
|
Suzy DePrizio
Chief Marketing Officer & Senior Vice President |
|
Tanya McNally
Chief People Officer & Senior Vice President |
|
Theodore Rapp Samuels
Independent Director |
|
Thomas R. Greco
Director |
|
Wade A. Rakes
Chief Growth Officer |
|
Wayne S. DeVeydt
Independent Director |